DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors

Angelo B A Laranjeira1, Melinda G Hollingshead1, Dat Nguyen1

  • 1Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.

Scientific Reports
|April 12, 2023
PubMed

Insights

DNA methyltransferase inhibitor (DNMTi) anticancer activity depends on DNA damage, not just demethylation. DNMT1 gene deletion reduces drug effectiveness, suggesting patients with these deletions may not benefit from DNMTi treatment.

Area of Science:

  • Oncology
  • Cancer Biology
  • Epigenetics

Background:

  • The precise role of DNA damage and demethylation in the anticancer efficacy of DNA methyltransferase inhibitors (DNMTi) is not fully understood.
  • Investigating the impact of DNMT1 gene status on DNMTi response is crucial for optimizing cancer therapy.

Purpose of the Study:

  • To elucidate the effect of DNMT1 gene deletion/disruption on the anticancer activity of DNMTi.
  • To assess the influence of DNMT1 status on drug-induced DNA damage, cell cycle arrest, apoptosis, and gene expression in various cancer models.

Main Methods:

  • In vitro studies using colon and breast cancer cell lines with and without DNMT1.
  • In vivo studies involving mouse xenograft and patient-derived xenograft (PDX) tumor models.
  • Analysis of human colon cancer samples for DNMT1 gene deletion frequency.

Main Results:

  • DNMT1 gene deletion significantly attenuated the cytotoxicity and growth inhibition caused by decitabine, azacitidine, and aza-T-dCyd.
  • DNMTi induced DNA damage, G2/M cell cycle arrest, apoptosis, and p21 upregulation in DNMT1+/+ cells, effects diminished in DNMT1-/- cells.
  • DNMT1 deletion was observed in approximately 9% of human colon cancers, conferring resistance to DNMTi and impacting treatment response.

Conclusions:

  • DNMT1 gene deletion confers resistance to DNMTi, indicating that their anticancer activity is primarily mediated by DNA damage effects.
  • The re-expression of p16INK4A/p15INK4B via demethylation and histone acetylation occurs independently of DNMT1 status.
  • Patients with DNMT1 gene deletions may exhibit a reduced response to DNMTi therapy, necessitating personalized treatment strategies.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
252
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
59
DNA Helicases00:55

DNA Helicases

DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
21.7K